NCT05150626View on ClinicalTrials.gov

A Study to Evaluate the Effect of Different Meal Types on the Pharmacokinetics of DBPR108 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

May 29, 2022

Primary Completion Date

June 7, 2022

Study Completion Date

July 14, 2022

Conditions

Healthy Subjects

Interventions

DRUG

DBPR108 tablets

Drug: DBPR108, tablets, oral

Trial Locations (1)

Unknown

First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors

lead

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

INDUSTRY